2003
DOI: 10.1016/j.ejps.2003.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
30
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(37 citation statements)
references
References 19 publications
7
30
0
Order By: Relevance
“…In the present studies, loperamide was more potent in mice than in rats, consistent with the significant increased murine potency observed by others [15] . Generally, loperamide acts at peripheral opioid receptors [16] to decrease both small intestinal and colonic transit [17][18][19][20] , but its effects in IBS diarrhea are variable and primarily associated with reduced urgency [17] .…”
Section: Discussionsupporting
confidence: 79%
“…In the present studies, loperamide was more potent in mice than in rats, consistent with the significant increased murine potency observed by others [15] . Generally, loperamide acts at peripheral opioid receptors [16] to decrease both small intestinal and colonic transit [17][18][19][20] , but its effects in IBS diarrhea are variable and primarily associated with reduced urgency [17] .…”
Section: Discussionsupporting
confidence: 79%
“…8A]. Loperamide decreased ITR%, which is consistent with the results of previous studies [34], and MOE inhibited this loperamide-induced ITR% decrease [ITR% for loperamide was 34.4 ± 1.5%, while it was 46.1 ± 0.8% for loperamide with MOE ( p < 0.001); Fig. 8A].…”
Section: Resultssupporting
confidence: 81%
“…To test whether the observed small-intestinal hypermotility contributed to the clearance of Giardia, we treated mice with loperamide, a drug that inhibits intestinal transit by activating -opioid receptors in the gastrointestinal tract (2,13,21). Drug treatment was started at the time of peak G. muris infection (day 7) to ensure that pharmacologically induced changes in motility would not interfere with the initial establishment of the infection.…”
mentioning
confidence: 99%